Peter Dynoodt
AeroLeads people directory · profile

Peter Dynoodt Email & Phone Number

Product Development Scientist at OncoMark at OncoMark
Location: Ireland, Ireland, Ireland 8 work roles 4 schools
1 work email found @oncomark.com LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email p****@oncomark.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Product Development Scientist at OncoMark
Location
Ireland, Ireland, Ireland
Company size

Who is Peter Dynoodt? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Peter Dynoodt is listed as Product Development Scientist at OncoMark at OncoMark, a company with 12 employees, based in Ireland, Ireland, Ireland. AeroLeads shows a work email signal at oncomark.com and a matched LinkedIn profile for Peter Dynoodt.

Peter Dynoodt previously worked as Product Development Scientist at Oncomark and Experienced Researcher / qPCR expert at Oncomark. Peter Dynoodt holds L8 Higher Diploma, Biopharmaceutical & Medical Device Manufacturing from Tud & Innopharma.

Company email context

Email format at OncoMark

This section adds company-level context without repeating Peter Dynoodt's masked contact details.

{first}.{last}@oncomark.com
89% confidence

AeroLeads found 1 current-domain work email signal for Peter Dynoodt. Compare company email patterns before reaching out.

Profile bio

About Peter Dynoodt

-11 years of experience in research environment (wet and dry lab), including 5 years of in vitro diagnostic assay development in skin, colorectal, and breast cancers. Involved in successful ISO13485 certification and CE marking for IVD test, OncoMasTR. - Experience with validation of multi-biomarker panels.- Implementation of Good Laboratory Practices (GLP). - Multilingual Ph.D., M.Sc. in Molecular Biotechnology and M.Sc. in Bio-engineering.- International exposure: UGent, VIB, UCD, KULeuven, and OncoMark.- Cross-functional experience in biotechnology, bioinformatics, qPCR data analysis, IHC, innovation and entrepreneurship in life sciences.CORE COMPETENCES---------------------------------RESEARCH AND DEVELOPMENTBiotechnological research in top-level research institutions (VIB) and universities (UGent, KULeuven) in departments focused on pathology and oncology. Extensive experience with many biotechnological methods used in miRNA gene expression profiling research at DNA, mRNA, protein and cellular level.INNOVATIONFirst to perform miRNA profiling studies on an experimentally designed pigmentation model, resulting in industrial interest and provisional patent application. Development of a novel automated digital pathology technology for the detection of staining patterns in histopathology. PROJECT MANAGEMENTPh.D., post-doctoral and project management experience in simultaneous management of several EU funded research projects, involving international collaborations. Experience in supervising 1 masters, 2 post-docs, and 5 lab technicians during research projects. INFORMATICS/BIO-INFORMATICSExtensive expertise with the Microsoft Office package (Microsoft Word, Excel, PowerPoint), statistics (SPSS, Graphpad Prism and R programming), genome annotation (UCSC genome browser, Ensembl, NCBI/Entrez), pathway analysis (DAVID and Ingenuity Pathway Analysis), qPCR data analysis (qBase+), and scientific reference software (Endnote).

Listed skills include Molecular Biology, Pcr, Life Sciences, Cell Culture, and 26 others.

Current workplace

Peter Dynoodt's current company

Company context helps verify the profile and gives searchers a useful next step.

OncoMark
Oncomark
Product Development Scientist at OncoMark
dublin, dublin, ireland
Website
Employees
12
AeroLeads page
8 roles

Peter Dynoodt work experience

A career timeline built from the work history available for this profile.

Product Development Scientist

Current

Dublin, Ireland

  • OncoMasTR is a novel prognostic assay for early stage breast cancer currently being developed by OncoMark. This multi-biomarker qPCR panel will determine the risk of recurrence for early breast cancer patients as.
  • In vitro diagnostic (IVD) assay development
  • Preparation of and adherence to technical project plans to cover all stages… Show more OncoMasTR is a novel prognostic assay for early stage breast cancer currently being developed by OncoMark. This multi-biomarker.
  • Preparation of and adherence to technical project plans to cover all stages of product development (feasibility, verification, validation)
  • Compilation of IVDD files and associated documentation for CE-IVD products
  • Experience with Quality Management System (ISO 13485)
Jan 2016 - Present

Experienced Researcher / Qpcr Expert

Dublin, Ireland

  • Focusing on the development of multiplex qPCR companion diagnostic that can register Avastin response in colorectal cancer patients (AngioPredict project for European Union (EU) Seventh Framework Programme (FP7)).Core.
  • Project management and leadership under strict timelines
  • Optimization of qPCR workflow/assay
  • Validation of qPCR companion diagnostic on FFPE and frozen patient samples
  • Reporting of deliverables and final reports to EU… Show more Focusing on the development of multiplex qPCR companion diagnostic that can register Avastin response in colorectal cancer patients (AngioPredict project for.
  • Reporting of deliverables and final reports to EU collaborators
Aug 2015 - Jan 2016

Scientist / Consultant

Current
Mircutis

miRcutis is the first biotechnology company to harness leading edge discoveries in gene expression to the consumer products sector. The Company is developing the first generation of ribo-nucleic acid (RNA)-based biological active ingredients for use in the skincare market. The miRcutis technology platform RNA mediated phenotype modulation™ (RPM) is the.

Apr 2016 - Present

Seconded Marie Curie Postdoctoral Experienced Researcher

Leuven, Belgium

Seconded fellow for Industry-Academia Partnerships and Pathways (IAPP) on a project based on Systems-Based View of Melanoma Progression: Towards Novel Diagnostic (and Therapeutic) Application. An extension to the SYS-MEL project in close collaboration with pathologists.

Feb 2015 - Jul 2015

Recruited Marie Curie (Iapp) Postdoctoral Experienced Researcher

Dublin, Ireland

  • Antibody optimization and immunochemistry (IHC) staining.
  • Manual and automated image analysis of tissue micro-array data (TMA) data.
  • Systems biological analysis of epigenomic signature/panel.
  • Distribution of clinical resources.
  • Protein expression analysis via IHC.
  • DTIC-SYSACT modeling of quantitative IHC results with clinical outcome.SYS-MEL is focused on developing prognostic and predictive tests for melanoma, the most aggressive form of skin cancer… Show more
Nov 2013 - Jan 2015

Phd

Ghent, Belgium

Aim: The detection of miRNAs involved in the pigmentary process in mammalians as the first step in the aim to interfere with the effect of miRNAs on the pigmentary process. Additional investigations into the potential role of miR-145 during progression of melanoma

Apr 2008 - Apr 2013

Junior Technician

Zwijnaarde, Ghent

Involved in a project that investigates the feasibility and the utility of double strand break induction to mediate and direct genome engineering in canola. Different components are tested through assays for functionality of double strand break induction and intra-chromosomal homologous recombination that hopefully leads to marker removal or specific gene.

Jun 2006 - Nov 2006

Internship

Flemish Interuniversity Institute For Biotechnology (Vib)

Zwijnaarde, Ghent

Unraveling the role of hormones during nodule senescence with the use of specific nodule promoter to drive the expression of specific hormone biosynthesis and perception/signaling interfering genes in the nodule.

Oct 2004 - Jul 2005
4 education records

Peter Dynoodt education

L8 Higher Diploma, Biopharmaceutical & Medical Device Manufacturing

Tud & Innopharma

Master, Industrial Engineering Agriculture And Biotechnology

FAQ

Frequently asked questions about Peter Dynoodt

Quick answers generated from the profile data available on this page.

What company does Peter Dynoodt work for?

Peter Dynoodt works for OncoMark.

What is Peter Dynoodt's role at OncoMark?

Peter Dynoodt is listed as Product Development Scientist at OncoMark at OncoMark.

What is Peter Dynoodt's email address?

AeroLeads has found 1 work email signal at @oncomark.com for Peter Dynoodt at OncoMark.

Where is Peter Dynoodt based?

Peter Dynoodt is based in Ireland, Ireland, Ireland while working with OncoMark.

What companies has Peter Dynoodt worked for?

Peter Dynoodt has worked for Oncomark, Mircutis, Kuleuven, University Hospital Of Ghent, Dermatology Research Unit, and Bayer Cropscience.

Who are Peter Dynoodt's colleagues at OncoMark?

Peter Dynoodt's colleagues at OncoMark include Ridho Raka and Joni Kemot Kemot.

How can I contact Peter Dynoodt?

You can use AeroLeads to view verified contact signals for Peter Dynoodt at OncoMark, including work email, phone, and LinkedIn data when available.

What schools did Peter Dynoodt attend?

Peter Dynoodt holds L8 Higher Diploma, Biopharmaceutical & Medical Device Manufacturing from Tud & Innopharma.

What skills is Peter Dynoodt known for?

Peter Dynoodt is listed with skills including Molecular Biology, Pcr, Life Sciences, Cell Culture, Biotechnology, Cell Biology, Research, and Lifesciences.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.